HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depression-like behaviors and heme oxygenase-1 are regulated by Lycopene in lipopolysaccharide-induced neuroinflammation.

Abstract
Previous studies have demonstrated that lycopene possesses anti-inflammatory properties in the central nervous system. However, the potential role and the molecular mechanisms of lycopene in lipopolysaccharide (LPS)-challenge inflammation and depression-like behaviors has not been clearly investigated. The present study aimed to assess the effects and the potential mechanisms of lycopene on LPS-induced depression-like behaviors. Lycopene was orally administered (60mg/kg) every day for seven days followed by intraperitoneal LPS injection (1mg/kg). The Forced swim test and tail suspension test were used to detect changes in the depression-like behaviors. ELISA was used to measure the expression of interleukin-6 (IL-6) and tumor necrosis factor-α(TNF-α) in the plasma. Immunoblotting was performed to measure the expression of interleukin-1β (IL-1β) and heme oxygenase-1 (HO-1) in the hippocampus. The results showed that pretreatment with lycopene could ameliorate depression-like behaviors. Moreover, lycopene relieved neuronal cell injury in hippocampal CA1 regions. Furthermore, lycopene decreased LPS-induced expression of IL-1β and HO-1 in the hippocampus together with decreasing level of IL-6 and TNF-α in the plasma. Taken together, these results suggest that lycopene can attenuate LPS-induced inflammation and depression-like behaviors, which may be involved in regulating HO-1 in the hippocampus.
AuthorsFang Zhang, Yanyan Fu, Xiaoyan Zhou, Wei Pan, Yue Shi, Mei Wang, Xunbao Zhang, Dashi Qi, Lei Li, Kai Ma, Renxian Tang, Kuiyang Zheng, Yuanjian Song
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 298 Pg. 1-8 (09 15 2016) ISSN: 1872-8421 [Electronic] Netherlands
PMID27609268 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Antioxidants
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Carotenoids
  • Heme Oxygenase-1
  • Lycopene
Topics
  • Animals
  • Antioxidants (therapeutic use)
  • Carotenoids (therapeutic use)
  • Depression (blood, drug therapy, etiology)
  • Encephalitis (chemically induced, complications)
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation (drug effects)
  • Heme Oxygenase-1 (metabolism)
  • Hippocampus (drug effects, metabolism)
  • Interleukin-6 (blood)
  • Lipopolysaccharides (toxicity)
  • Lycopene
  • Mice
  • Mice, Inbred ICR
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: